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PRIMARY SCREENING OF THE BIOLOGICAL ACTIVITY OF HETEROCYCLIC AMI-
NODERIVATIVES OF 2,3-DICHLORO-1,4-NAPHTOQUINONE 
N. Polish, O. Voitsakhivska, N. Marintsova, L. Zhurakhivska, V. Novikov, S. Bohza
Мета. Провести дослідження антимікробної та фунгіцидної активностей амінопіразольних похідних 
2,3-дихлоро-1,4-нафтохінону та спрогнозувати їхню гостру токсичність. 
Матеріали та методи дослідження. Протимікробну активність гетероциклічних амінопохідних наф-
тохінону 3a-d вивчали шляхом дифузії речовини в агар на твердому поживному середовищі та методом 
серійних розведень. Гостру токсичність для гризунів визначали методом моделювання QSAR, реалізова-
ним в програмному забезпеченні GUSAR .  
Результати. У роботі досліджено антимікробну та фунгіцидну активності нових гетероциклічних 
амінопохідних нафтохінону, а також проведено визначення їх in silico гострої токсичності для щурів за 
чотирма типами введення субстанції. 
Висновки. Дослідження амінопіразольних похідних нафтохінону дозволило виявити сполуки, які прояв-
ляють високу антимікробну активність по відношенню до тест-культури Candida tenuis, а саме:  
2-хлоро-3-((1-метил-1Н-піразол-4-іл)аміно)нафтален-1,4-діон 3a та 2-хлоро-3-((1-метил-1Н-піразол-3-
іл)аміно)нафтален-1,4-діон 3b. Встановлено, що усі синтезовані сполуки проявляють вибіркову бакте-
ріо- і фунгістатичну активності. Визначено методом QSAR нетоксичну сполуку 3с при внутрішньоче-
ревному шляху введення, а також нетоксичну сполуку 3d при підшкірному шляху введення
Ключові слова: амінопіразолопохідні 2,3-дихлоро-1,4-нафтохінону, первинний біологічний скринінг, про-
грама GUSAR
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1 Introduction 
Due to the increasing resistance of microorgan-
isms to existing antimicrobial and fungicidal prepara-
tions, it is of great relevance to search for new biological-
ly active compounds that could be used in the future for 
the production of low-toxic, microbial resistant drugs. 
That is why heterocyclic amino derivatives of naphtho-
quinone, which have a wide range of pharmacological 
activity, in particular, antibacterial [1, 2] antifungal [3], 
anticancer [4, 5], antiviral, anti-inflammatory and regen-
erating [6], occupy an important place among develop-
ment of new drug substances. 
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The priority for today is the creation of new high-
ly effective, low-toxic, antibacterial drugs as opposed to 
existing low-active ones. That is why research of new 
objects containing quinone and pyrazole fragments is an 
urgent task today. 
Many sources of naphthoquinone derivatives 
that make up the class of natural compounds are listed 
in the literature: pigments, antibiotics, vitamins, co-
enzymes [7–9]. Synthetic naphthoquinone compounds 
are the basis of antibacterial, antifungal, antitumor 
and antimalarial agents [1, 10, 11]. It has been report-
ed that some heterocyclic amino derivatives of naph-
thoquinone have antifungal activity [3]. Synthetic 
thiol derivatives containing 1,4-naphthoquinone have 
been reported as potent antimicrobial and anticancer 
agents [2, 10]. However, the toxicity of naphthoqui-
none compared to antibacterial activity often prevents 
their use as drugs for the treatment of infectious dis-
eases [12, 13]. 
It is also known that aminopyrazole derivatives 
are a component of effective drugs [14, 15]. Among 
them, a rare compound for the pyrazoles is the nucleo-
side antibiotic Pyrazofurin (1). Also noteworthy is the 
broad-spectrum lantibiotic Formicin (2) isolated from 
Bacillus paralicheniformis APC 1576. Effective non-
steroidal anti-inflammatory drugs such as Celecoxib (3) 
and Butadione (Phenylbutazone) (4) also should be men-
tioned [16, 17, 20].   
  
 
Pyrazofurin   Formicin   Celecoxib  Phenylbutazone 
 
 
The introduction of an aminopyrazole fragments 
likely reduces toxicity and broadens the biological activi-
ty spectrum of the compounds. 
The aim of our study is the primary screening of 
the biological activity of aminopyrazole naphthoquinone 
derivatives and in silico the determination of their acute 
toxicity in rats for rats by four types of substance admin-
istration.  
 
2. Planning (methodology) of research 
The search for new antimicrobial and fungicidal 
agents is one of the important tasks of scientists of the 
present day, which are solved by the synthesis of new 
biologically active molecules [20]. 
To achieve this aim, the following tasks were set: 
1) determine the biological activity of the first 
time synthesized compounds; 
2) determine acute toxicity to rodents by the 
QSAR simulation method. 
The following test strains were used for primary 
screening of biological activity carried out in accordance 
with WHO guidelines [18]: Escherichia coli, Staphylo-
coccus aureus, Mycobacterium luteum and fungi: Can-
dida tenuis, Aspergillus niger. The inoculum suspension 
was prepared using a Densi-La-Meter apparatus (manu-
factured by PLIVALachema, Czech Republic; wave-
length 540 nm). 
The suspension was prepared according to the de-
vice manual and information sheet No. 163-2006 "Standard-
ization of preparation of microbial suspensions" (Kyiv) on 
innovations in health care system. The inoculum density 
was 109 cells (spores) / 1 ml compared to the McFarland 
Standard [19]. For antimicrobial evaluation we used Muller-
Hinton agar. Antibacterial activity was assessed by measur-
ing the zones of inhibition of the corresponding microorgan-
ism and compared with the zones of the reference prepara-
tions Nystatin (antimicrobial) and Vancomycin (fungicidal). 
Acute rodent toxicity was determined by the QSAR 
simulation method using a free, accessible web service 
http://www.pharmaexpert.com/GUSAR/AcuToxPredict/). 
 
3. Materials and methods 
Due to the special value of naphthoquinonesand 
aminopyrazoles, the synthesis and research of new com-
pounds containing both the pyrazole cycle and the quin-
oid bond system are of particular interest. 
Antimicrobial and fungicidal activity studies were 
performed for newly synthesized naphthoquinone-
containing nitrogen derivatives. The scheme and method 
of synthesis are shown in Fig. 1 [20]. 
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Fig. 1. Synthesis scheme of heterocyclic amino derivatives of 2,3-dichloro-1,4-naphthoquinone 
 
The antimicrobial activity of the synthesized com-
pounds 3a-d was studied by diffusion into agar on solid 
nutrient medium (beef agar extract for bacteria, wort agar 
for fungi). For all tested microorganisms, Petri dishes con-
taining 20 ml of culture medium were used. The inoculum 
(microbial loading – 109 cells (spores) / 1 ml) was applied 
to the surface of solidified media and Whatman No. 1 fil-
tered disks (6 mm diameter) impregnated with the test com-
pounds (0.1 and 0.5 %) and placed on plates. The duration 
of bacterial incubation was 24 h at 35 °C and the incubation 
of fungi 48-72 h at 28–30 °C. The antimicrobial effect and 
the degree of activity of the tested compounds was evaluat-
ed by measuring the diameters of the zones of inhibition of 
growth of microorganisms (Table 1). Each experiment was 
repeated three times. 
Table 1 
Parameters of evaluation of results by the method 
of complex diffusion in agar 
No. 
The diameter of the zone 
of inhibition of growth of 
microorganisms, mm 
The degree of 
sensitivity of 
microorganisms 
1. 11–15 low sensitivity 
2. 16–25 sensitive 
3. >25 highly sensitive 
 
4. Results of the research 
The main results of the study of fungicidal ac-
tivity of compounds 3a-d by the method of diffusion 
of the substance into agar (method A) are shown in 
Table 2. 
 
Table 2 
Fungibactericidal activity of test compounds (method A) 
Compound code Concentration, % 
The diameter of the zones of inhibition of growth of microorganisms, 
mm 
E.coli S.aureus M.luteum C.tenuis A.niger 
3a 0.5 0 15.4 13.0 24.0 20.0 
0.1 0 7.4 0 20.0 17.0 
3b 0.5 0 10.0 9.7 25.4 20.0 
0.1 0 0 0 21.4 17.0 
3c 0.5 0 0 10.0 0 0 
0.1 0 0 7.0 0 0 
3d 0.5 0 10.4 15.0 0 10.0 
0.1 0 7.0 10.0 0 8.0 
Ca 0.1 14.0 15.0 18.0 19.0 20.0 
Note: Ca: Vancomycin was used as a control in the antimicrobial activity tests of the synthesized compounds, and Nystatin was used 
in the antifungal activity tests 
 
Determination of the minimum bacteriostatic 
concentration (MBC) or minimum fungistatic concen-
tration (MFC) was performed by serial dilution meth-
od (method B). The test substance was dissolved in 
DMSO to achieve the desired concentration. Next, a 
certain amount of the solution of the substance was 
introduced into the nutrient medium (meat-peptone 
broth for bacteria and unhilled beer must for fungi). 
The culture medium was inoculated with bacteria and 
fungi seed (microbial load of 106 cells (spores)/1 ml). 
Seed tubes were kept in a thermostat at the appropriate 
temperature (37 °C for bacteria; 30 °C for fungi) for 
24–72 hours. The results were evaluated in the pres-
ence or absence of growth of microorganisms (accord-
ing to the degree of microbial turbidity of the nutrient 
medium). 
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Bacterial test cultures were used to study the an-
timicrobial activity of the obtained compounds 3a-d: 
Escherichia coli, Staphylococcus aureus, Mycobacterium 
luteum and fungi: Candida tenuis, Aspergillus niger. 
The gram-negative culture of E. coli bacteria was 
found to be resistant to the synthesized compounds 3a–3d 
at the tested concentration. The most active compounds 
against C.tenuis identified by the serial dilution method are 
compounds 3a (MIC=0.9 μg/ml, MFC=1.9 μg/ml) and 3b 
(MIC=7.8 μg/ml, MFC=15.6 µg/ml) (Table 4). The di-
ameters of C.tenuis culture growth inhibition zones for 
these compounds at a concentration of 0.5 % were  
24.0 mm and 25.0 mm, respectively, indicating the high 
sensitivity of this bacterial culture to the action of these 
compounds. This is higher than Nystatin. Compounds 3a, 
3b, 3d showed moderate activity against the bacteria of 
the strain A.niger and S.aureus. Compared with Vanco-
mycin, compound 3a at a concentration of 0.5 % showed 
the same activity against S.aureus. The other compounds 
3b-d are less active. 
It was also found that all of our tested compounds 
3a–d showed moderate activity against bacteria of the M. 
luteum strain. 
The results of the initial experimental microbio-
logical studies indicate the selective bacterio- and fungi-
static activity of the synthesized compounds (Tab. 3). 
 
 
Table 3 
Indicators of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of compounds 
by serial dilution method (method B) 
No. 
Compound 
code 
Bacterial cultures 
Escherichia coli Staphylococcus aureus Mycobacterium luteum 
MIC, 
μg/ml 
MBC, 
μg/ml 
MIC, 
μg/ml 
MBC, 
μg/ml 
MIC, 
μg/ml 
MBC, 
μg/ml 
1. 3a + + 31.2 62.5 7.8 15.6 
2. 3b + + 31.2 62.5 7.8 15.6 
3. 3c + + + + 31.2 125.0 
4. 3d + + 125.0 250.0 15.6 31.2 
 
Table 4 
Indicators of minimum fungicidal concentration (MFC) and minimum inhibitory concentration (MIC) of com-
pounds by serial dilution method (method B) 
No. Compound cod
Bacterial cultures 
Candida tenuis Aspergillus niger 
MIC, 
μg/ml 
MFC, 
μg/ml 
MIC, 
μg/ml 
MFC, 
μg/ml 
1. 3a 0.9 1.9 0.9 15.6 
2. 3b 7.8 15.6 7.8 31.2 
3. 3c + + + + 
4. 3d 250.0 500.0 62.5 250.0 
Note: «+» – no biocidal effect was observed in the tested concentrations (microbial growth was observed) 
 
 
The rodent acute toxicity assessment is an ex-
tremely important feature in the development of new 
drugs. However, given the relatively high cost of such 
experimental studies and ethical considerations, we 
used the prediction of acute toxicity of aminopyrazole 
naphthoquinonederivatives to rats using a free, accessi-
ble web service (http://www.pharmaexpert.ru/GUSAR/ 
AcuToxPredict/) for various routes of administration of 
substances (intraperitoneal, intravenous, oral and subcu-
taneous). This is a method for modelling acute toxicity 
for QSAR rodents, implemented in GUSAR software 
[19]. Acute toxicity is an important adverse effect (or 
death) that occurs shortly after a single dose of the 
substance has started. The LD50 value is one of the 
important characteristics of acute toxicity correspond-
ing to a dose that causes 50 % mortality within 24 hours 
after administration of the substance. Acute toxicity, 
determined by external, oral or inhalation administra-
tion of the substance, is an important parameter for 
assessing overall toxicological risk, whereas acute tox-
icity for intra-intravenous and intravenous substance 
administration is an important parameter for drug de-
velopment. There is a large amount of data in the litera-
ture and databases on the LD50 of different compounds 
for rats, which enables the evaluation of LD50 in silico 
using different QSAR methods [22]. The results of the 
studies are presented in Table 5. The results of the acute 
toxicity prediction show that the synthesized aminopy-
razole derivatives of naphthoquinone can obviously be 
considered as low toxicity drugs (4, 5 class toxicity). In 
addition, the predicted data indicate that compound 3c 
is non-toxic in the intraperitoneal route of administra-
tion, and compound 3d is non-toxic in the subcutaneous 
route of administration. 
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Table 5  
Predicted acute toxicity of synthesized aminopyrazole naphthoquinone derivatives for rats 
Com-
pound 
No. 
Intraperitoneal route of 
administration 
Intravenous route of administra-
tion 
Oral route of administration 
Subcutaneous route of admin-
istration 
LD50 
(mg/kg) 
Classification 
of substance 
toxicity * 
LD50 (mg/kg) 
Classification of 
ubstance toxicity * 
LD50 (mg/kg) 
Classifica-
tion of sub-
stance tox-
icity * 
LD50 (mg/kg) 
Classification 
of substance 
toxicity* 
3a 675.300 Class 5 108.700 Class 4 730.700 Class 4 727.300 Class 4 
3b 760.600 Class 5 113.600 Class 4 672.200 Class 4 753.600 Class 4 
3c 1282.000 Non Toxic 86.480 Class 4 1479.000 Class 4 536.500 Class 4 
3d 1095.000 Class 5 94.950 Class 4 1537.000 Class 4 2590.00 Non Toxic 
Note: * – Acute rodent toxicity classification by OECD project (Organization for Economic Cooperation and Development) 
Therefore, the initial screening of the biological 
activity and toxicity of the synthesized compounds indi-
cate the high feasibility of further experimental preclini-
cal studies in order to find new effective drug substances.  
5. Discussion of the results
As a result of a study of the fungicidal activity of
aminopyrazole naphthoquinone derivatives by methods A 
and B, it was found that the most active among the tested 
compounds is 2-chloro-3-((1-methyl-1H-pyrazol-4-
yl)amino) naphthalene-1,4-dione 3a and 2-chloro-3-((1-
methyl-1H-pyrazol-3-yl)amino) naphthalene-1,4-dione 3b, 
which exhibit a wide range of fungicidal activity and mod-
erate bacterial culture activity of M. luteum strain. Ethyl-4-
(((3-chloro-1,4-dioxo-1,4-dihydrona-phthalen-2-yl)amino)- 
1-phenyl-1H-pyrazole-3-carboxy-late 3d exhibits little
fungicidal activity against test cultures, except E. coli,
whose growth is not affected by any of our compounds.
Moderate activity against bacteria of the M. luteum strain
exhibits 2-chloro-3-((3-(p-tolyl) -1H-pyrazol-5-yl) amino)
naphthalene-1,4-dione 3c.
When comparing the test compounds with the 
standards in the diameter of the zones of growth inhibi-
tion of microorganisms (Tab. 2) we found that com-
pounds 3a and 3b have slightly higher fungicidal activity 
than Nystatin. The antimicrobial activity of compound 3a 
is similar to Vancomycin.  
Conducted in silico toxicity spectrum studies of 
the compounds 3a – 3d under study indicate their pre-
dicted low toxicity. To confirm the predicted low toxicity 
of heterocyclic naphthoquinone derivatives, it is advisa-
ble to conduct further in vivo studies. 
When comparing the fungicidal activity of the 
compounds studied by us with those of other naphthoqui-
none S-derivatives [2]: 2-chloro-3-{[3-(2-methylfuran-3-
yl)-5-thioxo-1,5-dihydro-4H-1,2,4-triazol-4-yl] amino} 
naphthalene-1,4-dione, 2-{[4-amino-5-(2-methylfuran-3-yl) 
-4H-1,2,4-triazol-3-yl]sulfanyl}-3-chloronaphthalene-1,4-
dione and 2-chloro-3-{[3-(3-methylfuran-2-yl)-5-thioxo-
1,5-dihydro-4H-1,2,4-triazol-4-yl]amino}naphthalene-1 by
4-dione, it was found that S-substituted naphthoquinones
exhibit high activity against S. aureus strain and low 
against C.tenuis and M. luteum strains. N-substituted naph-
thoquinones, on the contrary, are highly active against 
C.tenuis and M.luteum strains. This proves the relation- 
ship between the structure of the compounds and
their activity.
Study limitations. When developing new drugs, 
it is important to assess their acute toxicity on rodents. 
However, such experimental studies are quite expensive, 
and they are constantly criticized for ethical reasons. 
Prospects for further research. Therefore, the 
results of our studies indicate the need for further phar-
macological screening of aminopyrazole derivatives of 
naphthoquinone in order to create new low-toxic antimi-
crobial and fungicidal agents based on them. 
Given the informative nature of the screening 
results, it is possible to continue studying their activity 
against a larger sample of clinical strains of microor-
ganisms. The properties of the basic structures thus 
identified need to be further optimized by the synthe-
sis and investigation of a large number of their ana-
logues.  
7. Conclusions
The antimicrobial activity of aminopyrazole naph-
thoquinone derivatives was investigated and found that 
2-chloro-3-((1-methyl-1H-pyrazol-4-yl)amino) naphtha-
lene-1,4-dione (3a) and 2-chloro-3-((1-methyl-1H-
pyrazol-3-yl)amino) naphthalene-1,4-dione (3b) exhibit
high antimicrobial activity against Candida tenuis test
culture. All the compounds tested do not affect the
growth of bacteria of the genus Escherichia coli. The
results of the initial experimental microbiological studies
indicate the selective bacterio- and fungistatic activity of
the nitrogen-containing heterocyclic naphthoquinone
derivatives. The test compounds can be attributed to low-
toxic drugs, and therefore it is advisable to conduct fur-
ther experimental studies of these substances.
Conflict of interests 
Authors declare no conflict of interests 
References 
1. Janeczko, M., Demchuk, O. M., Strzelecka, D., Kubiński, K., Masłyk, M. (2016). New family of antimicrobial agents
derived from 1,4-naphthoquinone. European Journal of Medicinal Chemistry, 124, 1019–1025. doi: http://doi.org/10.1016/ 
j.ejmech.2016.10.034
2. Shakh, Y. U., Romanenko, I., Slesarchuk, M., Syngaevsky, V., Kovalchuk, O., Bolibrukh, K. et. al. (2017). Synthesis and
Antimicrobial Activity of 1,4-Naphthoquinones Derivatives with [1,2,4]-Triazole-3-thione Substitution. Indian Journal of 
Pharmaceutical Sciences, 79 (4), 650–654. doi: http://doi.org/10.4172/pharmaceutical-sciences.1000275  
3. Wellington, K. W., Kolesnikova, N. I., Nyoka, N. B. P., McGaw, L. J. (2018). Investigation of the antimicrobial and
anticancer activity of aminonaphthoquinones. Drug Development Research, 80 (1), 138–146. doi: http://doi.org/10.1002/ddr.21477 
Scientific Journal «ScienceRise: Pharmaceutical Science»      №6(22) 2019 
42 
4. Wellington, K. W. (2015). Understanding cancer and the anticancer activities of naphthoquinones – a review. RSC
Advances, 5 (26), 20309–20338. doi: http://doi.org/10.1039/c4ra13547d 
5. Ravichandiran, P., Subramaniyan, S. A., Kim, S. Y., Kim, J. S., Park, B. H., Shim, K. S., Yoo, D. J. (2019). Synthesis and
Anticancer Evaluation of 1, 4Naphthoquinone Derivatives Containing a Phenylaminosulfanyl Moiety. ChemMedChem, 14 (5), 
532–544. doi: http://doi.org/10.1002/cmdc.201800749 
6. Xu, K., Xiao, Z., Tang, Y. B., Huang, L., Chen, C.-H., Ohkoshi, E., Lee, K.-H. (2012). Design and synthesis of
naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors. Bioorganic & Medicinal Chemistry Letters,  
22 (8), 2772–2774. doi: http://doi.org/10.1016/j.bmcl.2012.02.086  
7. López López, L. I., Flores, N., Daniel, S., Silva Belmares, S. Y., Sáenz Galindo, A. (2014). Naphthoquinones: biological
properties and synthesis of lawsone and derivatives-a structured review. Vitae, 21 (3), 248–258. 
8. El-Najjar, N., Gali-Muhtasib, H., Ketola, R. A., Vuorela, P., Urtti, A., Vuorela, H. (2011). The chemical and biological
activities of quinones: overview and implications in analytical detection. Phytochemistry Reviews, 10 (3), 353–370. doi: 
http://doi.org/10.1007/s11101-011-9209-1  
9. Liu, F. (2012). Synthesis of natural products and small molecules using quinones. doi: http://doi.org/10.31274/etd-180810-2332
10. Ibis, C., Sahinler Ayla, S., Yavuz, S. (2019). Reactions of quinones with some aryl phenols and synthesis of new quinone
derivatives. Synthetic Communications, 49 (2), 202–211. doi: http://doi.org/10.1080/00397911.2018.1546403 
11. Ravichandiran, P., Kannan, R., Ramasubbu, A., Muthusubramanian, S., Samuel, V. K. (2016). Green synthesis of 1,4-
quinone derivatives and evaluation of their fluorescent and electrochemical properties. Journal of Saudi Chemical Society, 20, S93–
S99. doi: http://doi.org/10.1016/j.jscs.2012.09.011 
12. De Moraes, T., Filha, M., Camara, C., Silva, T., Soares, B., Bomfim, I. et. al. (2014). Synthesis and Cytotoxic Evaluation
of a Series of 2-Amino-Naphthoquinones against Human Cancer Cells. Molecules, 19 (9), 13188–13199. doi: http://doi.org/10.3390/ 
molecules190913188  
13. Sieveking, I., Thomas, P., Estévez, J. C., Quiñones, N., Cuéllar, M. A., Villena, J. et. al. (2014). 2-
Phenylaminonaphthoquinones and related compounds: Synthesis, trypanocidal and cytotoxic activities. Bioorganic & Medicinal 
Chemistry, 22 (17), 4609–4620. doi: http://doi.org/10.1016/j.bmc.2014.07.030  
14. Ansari, A., Ali, A., Asif, M., Shamsuzzaman, S. (2017). Review: biologically active pyrazole derivatives. New Journal of
Chemistry, 41 (1), 16–41. doi: http://doi.org/10.1039/c6nj03181a 
15. Jahangir, A. Md. et. al. (2015). A review on pyrazole chemical entity and biological activity. International Journal of
Pharmaceutical Sciences and Research, 6, 1433–1442. 
16. El Shehry, M. F., Ghorab, M. M., Abbas, S. Y., Fayed, E. A., Shedid, S. A., Ammar, Y. A. (2018). Quinoline derivatives
bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents. European Journal of 
Medicinal Chemistry, 143, 1463–1473. doi: http://doi.org/10.1016/j.ejmech.2017.10.046  
17. Rizk, H. F., Ibrahim, S. A., El-Borai, M. A. (2015). Synthesis, fastness properties, color assessment and antimicrobial
activity of some azo reactive dyes having pyrazole moiety. Dyes and Pigments, 112, 86–92. doi: http://doi.org/10.1016/ 
j.dyepig.2014.06.026
18. Coyle, M. B. (2005). Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology. Washington:
American Society for Microbiology, 236. 
19. McFarland, J. (1907). Nephelometer: An Instrument for Estimating the Number of Bacteria in Suspensions Used for
Calculating the Opsonic Index and for Vaccines. Journal of the American Medical Association, 49 (14), 1176–1178. doi: 
http://doi.org/10.1001/jama.1907.25320140022001f  
20. Polish, N. V., Marintsova, N. G., Zhurakhivska, L. R., Novikov, V. P., Vovk, M. V. (2019). Synthesis and prediction of
the biological activity of heterocyclic n-derivatives naphthoquinone. Chemistry, Technology and Application of Substances, 2 (1), 
69–75. doi: http://doi.org/10.23939/ctas2019.01.069  
21. Lagunin, A., Zakharov, A., Filimonov, D., Poroikov, V. (2011). QSAR Modelling of Rat Acute Toxicity on the Basis of
PASS Prediction. Molecular Informatics, 30 (2-3), 241–250. doi: http://doi.org/10.1002/minf.201000151 
Received date 22.11.2019 
Accepted date 19.12.2019 
Published date 30.12.2019 
Nataliia Polish, Postgraduate Student, Department of Technology Biologically Compounds, Pharmacy and Bio-
technology, Lviv Polytechnic National University, St. Bandery str., 12, Lviv, Ukraine, 79013. E-mail: 
polishn@ukr.net  
Olha Voitsakhivska, Department of Technology Biologically Compounds, Pharmacy and Biotechnology, Lviv 
Polytechnic National University, St. Bandery str., 12, Lviv, Ukraine, 79013. E-mail: olyavoitsahivska@gmail.com 
Nataliia Marintsova, PhD, Associate Professor, Department of Technology Biologically Compounds, Pharma-
cy and Biotechnology, Lviv Polytechnic National University, St. Bandery str., 12, Lviv, Ukraine, 79013 
E-mail: nmarintsova@gmail.com
Lesya Zhurakhivska, PhD, Associate Professor, Department of Technology Biologically Compounds, Pharma-
cy and Biotechnology, Lviv Polytechnic National University, St. Bandery str., 12, Lviv, Ukraine, 79013 
E-mail: zhurakhivska@ukr.net
Volodymyr Novikov, Doctor of Chemical Sciences, Professor, Department of Technology Biologically Com-
pounds, Pharmacy and Biotechnology, Lviv Polytechnic National University, St. Bandery str., 12, Lviv, Ukraine, 
79013. E-mail: volodymyr.p.novikov@lpnu.ua 
Bohza Serhii, Doctor of Chemical Sciences, Senior Researcher, Institute of Organic Chemistry of the National 
Academy of Sciences of Ukraine, Murmanska str., 5, Kyiv, Ukraine, 02660. E-mail: serge-bogza@yandex.ua 
